MTOR and Mental deterioration: SGLT2 inhibitors also reduce brain damage and cognitive decline through different aspects of brain protection, such as mitochondrial function, synaptic plasticity, acetylcholinesterase activity, amyloid plaques, and modulation of the mTOR pathway [37].